Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ILMN
Illumina, Inc.
Healthcare | Medical - Diagnostics & Research
$218.22-3.44 (-1.55%)as of 2026-09-04 20:20 UTC
Market Cap$33.0B
Volume1.68M
EPS (TTM)$5.45
Illumina, Inc. (NASDAQ: ILMN) is a $33.0B medical - diagnostics & research company trading at $218.22 (−1.6% today) — 40.0× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-09-04 20:20 UTC.
52-Week Range
Low $119.16High $231.81
What Illumina, Inc. does
The company provides sequencing and array-based solutions for genetic and genomic analysis used by research centers, academic institutions, government laboratories, hospitals, and pharmaceutical and biotechnology companies. Its integrated portfolio includes sequencing systems, microarray systems, consumables, and analysis tools designed for various genomic applications and customer needs. The company was incorporated in California in April 1998 and reincorporated in Delaware in July 2000, with principal offices in San Diego, California.
The company provides sequencing and array-based solutions for genetic and genomic analysis used by research centers, academic institutions, government laboratories, hospitals, and pharmaceutical and biotechnology companies.
What is ILMN's valuation?
ILMN trades at $218.22, 40.04× trailing earnings, 29.80× EV/EBITDA, as of 2026-09-04.
When did ILMN last file with the SEC?
Illumina, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-23. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-09-04 20:20 UTC. This page is also available as JSON at /api/data?ticker=ILMN and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ILMN and 5,000+ tickers.
